Papers/PMID:26408319
Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial.
BMC complementary and alternative medicine2015The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
Ilex paraguariensis — decreases fat mass
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“The decreased in body fat mass (P = 0.036) and percent body fat (P = 0.030) in the Yerba Mate group compared to the placebo group was significant.”
Quoted verbatim from Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 3150 mg/day Yerba Mate water extract (three capsules before each of three meals), 12 weeks
- Population
- Korean adults with obesity (BMI 25 to under 35 kg/m2 and elevated waist-hip ratio), mostly women, randomized to Yerba Mate or placebo capsules
Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial.2015PMID:26408319Industry fundedPermalink
Ilex paraguariensis — decreases waist-to-hip ratio
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Decreased WHR (P = 0.005) in the Yerba Mate group compared to the placebo group were significant.”
Quoted verbatim from Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 3150 mg/day Yerba Mate water extract (three capsules before each of three meals), 12 weeks
- Population
- Korean adults with obesity (BMI 25 to under 35 kg/m2 and elevated waist-hip ratio), mostly women, randomized to Yerba Mate or placebo capsules
Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial.2015PMID:26408319Industry fundedPermalink